Industry News
Biotechnology Industry News
Lilly invests in MiNA to fund trials of protein-upregulating RNA
Lilly invests in MiNA to fund trials of protein-upregulating RNA ntaylor Tue, 07/06/2021 - 07:58
Lilly invests in MiNA to fund trials of protein-upregulating RNA
Lilly invests in MiNA to fund trials of protein-upregulating RNA ntaylor Tue, 07/06/2021 - 07:58
Provention Bio slapped with FDA rejection for diabetes hopeful teplizumab
Provention Bio slapped with FDA rejection for diabetes hopeful teplizumab badams Tue, 07/06/2021 - 07:28
Provention Bio slapped with FDA rejection for diabetes hopeful teplizumab
Provention Bio slapped with FDA rejection for diabetes hopeful teplizumab badams Tue, 07/06/2021 - 07:28
Leo taps X-Chem to discover anti-inflammatory dermatology drugs
Leo taps X-Chem to discover anti-inflammatory dermatology drugs ntaylor Tue, 07/06/2021 - 07:16
Leo taps X-Chem to discover anti-inflammatory dermatology drugs
Leo taps X-Chem to discover anti-inflammatory dermatology drugs ntaylor Tue, 07/06/2021 - 07:16
Parexel snapped up, again, as Goldman Sachs, EQT spend $8.5B on the CRO
Parexel snapped up, again, as Goldman Sachs, EQT spend $8.5B on the CRO badams Fri, 07/02/2021 - 11:18
Parexel snapped up, again, as Goldman Sachs, EQT spend $8.5B on the CRO
Parexel snapped up, again, as Goldman Sachs, EQT spend $8.5B on the CRO badams Fri, 07/02/2021 - 11:18
Arrowhead slams brakes on early-stage cystic fibrosis study after rat study triggers lung inflammation concerns
Arrowhead slams brakes on early-stage cystic fibrosis study after rat study triggers lung inflammation concerns aarmstrong Fri, 07/02/2021 - 09:57
Arrowhead slams brakes on early-stage cystic fibrosis study after rat study triggers lung inflammation concerns
Arrowhead slams brakes on early-stage cystic fibrosis study after rat study triggers lung inflammation concerns aarmstrong Fri, 07/02/2021 - 09:57
Eschewing an IPO (for now), Sirnaomics nabs a rare series E worth $105M for next-gen RNA work
Eschewing an IPO (for now), Sirnaomics nabs a rare series E worth $105M for next-gen RNA work badams Fri, 07/02/2021 - 09:52
Eschewing an IPO (for now), Sirnaomics nabs a rare series E worth $105M for next-gen RNA work
Eschewing an IPO (for now), Sirnaomics nabs a rare series E worth $105M for next-gen RNA work badams Fri, 07/02/2021 - 09:52
New approach to triple-negative breast cancer targets tumor-driving RNA proteins
New approach to triple-negative breast cancer targets tumor-driving RNA proteins arlene.weintraub Fri, 07/02/2021 - 08:49
New approach to triple-negative breast cancer targets tumor-driving RNA proteins
New approach to triple-negative breast cancer targets tumor-driving RNA proteins arlene.weintraub Fri, 07/02/2021 - 08:49
Roche vet leaves Nordic Nanovector 3 months after joining as CEO
Roche vet leaves Nordic Nanovector 3 months after joining as CEO ntaylor Fri, 07/02/2021 - 08:06
Roche vet leaves Nordic Nanovector 3 months after joining as CEO
Roche vet leaves Nordic Nanovector 3 months after joining as CEO ntaylor Fri, 07/02/2021 - 08:06
Lundbeck sells off flopped Alzheimer’s drug as Aduhelm approval ups interest
Lundbeck sells off flopped Alzheimer's drug as Aduhelm approval ups interest ntaylor Fri, 07/02/2021 - 05:53
Lundbeck sells off flopped Alzheimer’s drug as Aduhelm approval ups interest
Lundbeck sells off flopped Alzheimer's drug as Aduhelm approval ups interest ntaylor Fri, 07/02/2021 - 05:53
GSK, under pressure to perform, pens $2.2B deal with Alector focused on neuro R&D, Alzheimer’s
GSK, under pressure to perform, pens $2.2B deal with Alector focused on neuro R&D, Alzheimer's badams Fri, 07/02/2021 - 04:18
GSK, under pressure to perform, pens $2.2B deal with Alector focused on neuro R&D, Alzheimer’s
GSK, under pressure to perform, pens $2.2B deal with Alector focused on neuro R&D, Alzheimer's badams Fri, 07/02/2021 - 04:18